H. Diedrich

4.6k total citations · 3 hit papers
34 papers, 2.8k citations indexed

About

H. Diedrich is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, H. Diedrich has authored 34 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 16 papers in Public Health, Environmental and Occupational Health and 9 papers in Genetics. Recurrent topics in H. Diedrich's work include Acute Lymphoblastic Leukemia research (16 papers), Acute Myeloid Leukemia Research (12 papers) and Chronic Myeloid Leukemia Treatments (12 papers). H. Diedrich is often cited by papers focused on Acute Lymphoblastic Leukemia research (16 papers), Acute Myeloid Leukemia Research (12 papers) and Chronic Myeloid Leukemia Treatments (12 papers). H. Diedrich collaborates with scholars based in Germany, United States and Italy. H. Diedrich's co-authors include Nicola Gökbuget, Albrecht Reichle, Heinz‐August Horst, Mathias Freund, Monika Brüggemann, Gerhard Zugmaier, Christoph Faul, Max S. Topp, Ralf C. Bargou and Dieter Hoelzer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

H. Diedrich

33 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia

2018 516 citations Nicola Gökbuget, Hervé Dombret et al. Blood profile →
Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia

2014 488 citations Max S. Topp, Nicola Gökbuget et al. profile →
Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults

1988 430 citations D. Hoelzer, Arnold Ganser et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Diedrich Germany	19	1.6k	1.4k	1.3k	457	454	34	2.8k
Heinz‐August Horst Germany	17	1.5k 1.0×	1.2k 0.9×	1.5k 1.2×	696 1.5×	295 0.6×	28	2.8k
Christoph Faul Germany	22	902 0.6×	1.1k 0.8×	1.3k 1.0×	445 1.0×	608 1.3×	82	2.5k
Thorsten Raff Germany	19	1.5k 0.9×	1.3k 0.9×	620 0.5×	853 1.9×	356 0.8×	32	2.6k
Cornelia Eckert Germany	29	1.8k 1.2×	1.5k 1.1×	655 0.5×	404 0.9×	290 0.6×	84	2.9k
Richard Ratei Germany	31	1.7k 1.1×	1.5k 1.1×	572 0.5×	376 0.8×	221 0.5×	60	2.7k
Hermann Kreyenberg Germany	27	879 0.6×	1.5k 1.0×	779 0.6×	133 0.3×	649 1.4×	62	2.4k
FG Behm United States	36	2.2k 1.4×	2.1k 1.5×	538 0.4×	386 0.8×	460 1.0×	65	3.4k
RK Dodge United States	20	979 0.6×	971 0.7×	308 0.2×	215 0.5×	218 0.5×	35	1.9k
DJ Pullen United States	34	3.2k 2.1×	2.6k 1.9×	511 0.4×	519 1.1×	314 0.7×	75	4.0k
F G Behm United States	30	2.1k 1.3×	2.0k 1.5×	403 0.3×	320 0.7×	306 0.7×	53	3.2k

Countries citing papers authored by H. Diedrich

Since Specialization

Citations

This map shows the geographic impact of H. Diedrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Diedrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Diedrich more than expected).

Fields of papers citing papers by H. Diedrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Diedrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Diedrich. The network helps show where H. Diedrich may publish in the future.

Co-authorship network of co-authors of H. Diedrich

This figure shows the co-authorship network connecting the top 25 collaborators of H. Diedrich. A scholar is included among the top collaborators of H. Diedrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Diedrich. H. Diedrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stadler, Michael, Lothar Hambach, Elke Dammann, et al.. (2023). The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease. Annals of Hematology. 102(9). 2529–2542. 4 indexed citations

Gökbuget, Nicola, Hervé Dombret, Massimiliano Bonifacio, et al.. (2018). Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia. Blood. 131(14). 1522–1531. 516 indexed citations breakdown →

Borchers, Sylvia, E. M. Weissinger, Brigitte Pabst, et al.. (2013). Expansion of recipient‐derived antiviral T cells may influence donor chimerism after allogeneic stem cell transplantation. Transplant Infectious Disease. 15(6). 627–633. 11 indexed citations

Borchers, Sylvia, Ulrich Lips, Michael Stadler, et al.. (2011). Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation. Transplant Infectious Disease. 13(3). 222–236. 44 indexed citations

Gökbuget, Nicola, Nadežda Basara, H. Baurmann, et al.. (2011). High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation. Blood. 118(13). 3504–3511. 126 indexed citations

Goekbuget, Nicola, Anja Baumann, Joachim Beck, et al.. (2008). PEG-Asparaginase in Adult Acute Lymphoblastic Leukemia (ALL): Efficacy and Feasibility Analysis with Increasing Dose Levels. Blood. 112(11). 302–302. 20 indexed citations

Burmeister, Thomas, Stefan Schwartz, Edgar Jost, et al.. (2007). Atypical BCR-ABL mRNA transcripts in adult Acute lymphoblastic leukemia. Haematologica. 92(12). 1699–1702. 31 indexed citations

Karthaus, Meinolf, Johannes Meran, Ludwig Wilkens, et al.. (1998). Fluorescence in situ Hybridization and Surface Markers of Fine Needle Aspiration Specimen Confirm Extramedullary Myelobastoma in a Patient with Chronic Myeloid Leukemia. Acta Haematologica. 100(2). 91–93. 2 indexed citations

Karthaus, Meinolf, Georg Brabant, Hartmut Link, et al.. (1997). Immune thyroiditis after transplantation of allogeneic CD34+ selected peripheral blood cells. Bone Marrow Transplantation. 20(8). 697–699. 34 indexed citations

10.

Link, Hartmut & H. Diedrich. (1996). Introduction to the economics and mathematics of financial markets. Medical Entomology and Zoology. 91 Suppl 3. 3–17. 3 indexed citations

11.

Arseniev, Lubomir, H. Diedrich, & Hartmut Link. (1996). Allogeneic bone marrow transplantation in a patieni with Shwachman-Diamond syndrome. Annals of Hematology. 72(2). 83–84. 31 indexed citations

12.

Link, Hartmut, Lubomir Arseniev, & H. Diedrich. (1996). Allogeneic bone marrow transplantation in a patient with Shwachman-Diamond syndrome. Annals of Hematology. 72(2). 83–84. 20 indexed citations

13.

Nolte, M., Martin Werner, Reinhard von Wasielewski, et al.. (1996). Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 427(6). 561–565. 14 indexed citations

14.

Arseniev, Lubomir, Reinhilde Jacobs, H. Diedrich, et al.. (1996). Technical and safety aspects of blood and marrow transplantation using G-CSF mobilized family donors. Transfusion Science. 17(4). 611–618. 4 indexed citations

15.

Link, Hartmut, Thomas Brune, G Hübner, et al.. (1993). Effect of recombinant human erythropoietin after allogeneic bone marrow transplantation. Annals of Hematology. 67(4). 169–173. 11 indexed citations

16.

Freund, Mathias, et al.. (1991). High-dose ara-C and etoposide in refractory or relapsing acute leukemia. Cancer Chemotherapy and Pharmacology. 28(6). 487–490. 4 indexed citations

17.

Link, Hartmut, M. Freund, H. Diedrich, et al.. (1990). Mitoxantrone, Cytosine Arabinoside, and VP-16 in 36 Patients with Relapsed and Refractory Acute Myeloid Leukemia. Hämatologie und Bluttransfusion. 33. 322–325. 10 indexed citations

18.

Freund, Mathias, Peter von Wussow, H. Diedrich, et al.. (1989). Recombinant human interferon (IFN) alpha‐2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti‐interferon antibodies. British Journal of Haematology. 72(3). 350–356. 75 indexed citations

19.

Wussow, Peter von, M. Freund, H. Diedrich, et al.. (1987). Niedrigdosierte IFN-α-Behandlung der Haarzelleukämie. Journal of Molecular Medicine. 65(14). 681–684.

20.

Freund, Mathias, Hartmut Link, H. Diedrich, & H. Poliwoda. (1986). High dose Ara-C and VP16 in treatment of refractory or relapsing acute leukemia. Journal of Cancer Research and Clinical Oncology. 111(S1). S107–S107. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact